Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.

Rybinnik I, Mullen MT, Messe S, Kasner SE, Cucchiara B.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1312-6. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.005. Epub 2013 Jan 10.

PMID:
23313461
2.

Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.

Kate M, Szkotak A, Witt A, Shuaib A, Butcher K.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1351-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.013. Epub 2014 Jan 7.

PMID:
24406026
3.

Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.

Diogo C, Duarte J, Sobral S, Pestana P, Nzwalo H, Rita H, Sousa E Costa J.

Am J Emerg Med. 2014 Nov;32(11):1435.e1-2. doi: 10.1016/j.ajem.2014.04.021. Epub 2014 Apr 18.

PMID:
24881517
4.

Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.

Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.

J Neurosci Res. 2014 Jan;92(1):46-53. doi: 10.1002/jnr.23302. Epub 2013 Nov 4.

5.

Intravenous thrombolysis in a stroke patient taking dabigatran.

Lee VH, Conners JJ, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):916.e11-2. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.008. Epub 2012 May 16.

PMID:
22608344
6.

Stroke thrombolysis in patients taking dabigatran.

Jayathissa S, Gommans J, Harper P.

Intern Med J. 2013 Jul;43(7):826-8. doi: 10.1111/imj.12182. Review.

PMID:
23841763
7.

Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.

Sangha N, El Khoury R, Misra V, Lopez G.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e5-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.003. Epub 2012 Jun 9.

PMID:
22683118
8.

Thrombolysis in ischemic stroke patients on treatment with Dabigatran.

Re G, Toni D.

Intern Emerg Med. 2013 Aug;8(5):451-2. doi: 10.1007/s11739-013-0907-0. Epub 2013 Feb 7. No abstract available.

PMID:
23389386
9.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Steiner T, Böhm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M, Laufs U, Nickenig G, Riess H, Röther J, Schellinger PD, Spannagl M, Veltkamp R.

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14. Review.

PMID:
23669868
10.

[Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature].

Inaishi J, Nogawa S, Mano Y, Yoshizaki T, Okada S.

Rinsho Shinkeigaku. 2014;54(3):238-40. Review. Japanese.

PMID:
24705841
11.

Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.

Marrone LC, Marrone AC.

Cerebrovasc Dis. 2012;34(3):246-7. doi: 10.1159/000342307. Epub 2012 Sep 26. No abstract available.

PMID:
23018342
12.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

13.

Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.

Ross B, Miller MA, Ditch K, Tran M.

J Med Toxicol. 2014 Jun;10(2):223-8. doi: 10.1007/s13181-013-0364-1.

14.

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1. No abstract available.

PMID:
22133608
15.

Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?

Pollack CV Jr, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA.

Am J Emerg Med. 2014 Nov;32(11):1433-4. doi: 10.1016/j.ajem.2014.08.072. Epub 2014 Aug 29. No abstract available.

PMID:
25239691
16.

Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.

Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.

Cerebrovasc Dis. 2013;35(5):461-8. doi: 10.1159/000350201. Epub 2013 May 31.

PMID:
23735898
17.

Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.

Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N.

Rev Neurol (Paris). 2015 Sep;171(8-9):613-5. doi: 10.1016/j.neurol.2015.02.012. Epub 2015 Apr 7.

PMID:
25857461
18.

Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.

Folyovich A, Varga V, Béres-Molnár KA, Vadasdi K, Bereczki D.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):580-2. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.029. Epub 2013 May 28.

PMID:
23721623
19.

Current status of intravenous thrombolysis for acute ischemic stroke in Asia.

Sharma VK, Ng KW, Venketasubramanian N, Saqqur M, Teoh HL, Kaul S, Srivastava PM, Sergentanis T, Suwanwela N, Nguyen TH, Lawrence Wong KS, Chan BP.

Int J Stroke. 2011 Dec;6(6):523-30. doi: 10.1111/j.1747-4949.2011.00671.x. Review.

PMID:
22111797
20.

Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.

Faust AC, Peterson EJ.

J Emerg Med. 2014 Apr;46(4):525-9. doi: 10.1016/j.jemermed.2013.11.097. Epub 2014 Feb 6.

PMID:
24508114

Supplemental Content

Support Center